pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›Furosemide
drug
save

Furosemide Sun

Marketedupdated 3mo ago
by Sun Pharmaceutical Industries Ltd
Approved
community read0 votes

Small molecule drug with a maximum clinical stage of Approval (across all indications), with 6 approved and 28 investigational indications.

indications

investigational
Hypertension

all catalysts(6)

approval · 6
Oct 7, 2022
approval
4y ago
FUROSCIX (FUROSEMIDE) — FDA approval
Furosemide Sun
→
Aug 9, 2024
approval
2y ago
FUROSCIX (FUROSEMIDE) — FDA approval
Furosemide Sun
→
Mar 6, 2025
approval
1y ago
FUROSCIX (FUROSEMIDE) — FDA approval
Furosemide Sun
→
Oct 7, 2025
approval
10mo ago
LASIX ONYU (FUROSEMIDE) — FDA approval
Furosemide Sun
→
Dec 22, 2025
approval
8mo ago
FUROSCIX (FUROSEMIDE) — FDA approval
Furosemide Sun
→
Jan 8, 2026
approval
7mo ago
FUROSEMIDE — FDA approval
Furosemide Sun
→

Trials studying Furosemide Sun

  • —Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infantsrecruitingn=1,600
  • phase1Comparison of Once Daily 40 mg Torsemide With Twice-daily 40 mg Furosemideterminatedn=20
  • phase1Study to Compare Bioavailability and Pharmacokinetics of a Novel Furosemide Regimen Administered Subcutaneously Versus the Same Dose (80 mg) Administered Intravenously in Healthy Volunteerscompletedn=16
  • phase1Pharmacokinetics and Pharmacodynamics of Subcutaneous vs Intravenous Furosemide in Healthy Volunteerscompletedn=21
  • phase1Modular Clinical Pharmacology Study to Evaluate the Drug-drug Interaction Potential and Relative Bioavailability of Saruparibactive not recruitingn=41
  • phase1A Clinical Study of the Effect of MK-2828 on Rosuvastatin or Furosemide in Healthy People (MK-2828-005)recruitingn=39
  • N/AA Study to Compare How Different Medicines (Rosuvastatin, Digoxin, Metformin, and Furosemide) Are Handled by the Body of Healthy People and People With Liver Cirrhosiscompletedn=28
  • phase1A Study in Healthy Men to Test Whether Zongertinib Influences the Amount of 4 Other Medicines (Dabigatran, Rosuvastatin, Metformin, and Furosemide) in the Bloodcompletedn=32
more trials →

Patent cliff

source: FDA Orange Book
first barrier falls
Apr 3, 2034
~7.6 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (4)

  • Apr 3, 2034formulationUS 10272064
  • Apr 3, 2034method-of-use (U-3462)US 11433044
  • Apr 3, 2034formulationUS 12370168
  • Apr 3, 2034method-of-use (U-3462)US 9884039

News(0)

no news has mentioned this drug yet

brand
Furosemide
generic
furosemide
MOA
Sodium-(potassium)-chloride cotransporter 2 inhibitor
indication
Hepatic Edema
phase
marketed
Data sources
openFDA · ClinicalTrials.gov
last refreshed 20m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?